Place of the partial dopamine receptor agonist aripiprazole in the management of schizophrenia in adults: a Delphi consensus study

BACKGROUND: Aripiprazole is a second-generation antipsychotic, efficacious in patients with schizophrenia during acute episodes. Due to its pharmacological profile, aripiprazole may be of interest in patients with specific clinical profiles who have not been studied extensively in randomised clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Llorca, Pierre-Michel, Nuss, Philippe, Fakra, Éric, Alamome, Isabelle, Drapier, Dominique, Hage, Wissam El, Jardri, Renaud, Mouchabac, Stéphane, Rabbani, Marc, Simon, Nicolas, Vacheron, Marie-Noëlle, Azorin, Jean-Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142729/
https://www.ncbi.nlm.nih.gov/pubmed/35643542
http://dx.doi.org/10.1186/s12888-022-04008-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142729/
https://www.ncbi.nlm.nih.gov/pubmed/35643542
http://dx.doi.org/10.1186/s12888-022-04008-9

Ejemplares similares